The Effects of Curcuminoids on Aberrant Crypt Foci in the Human Colon
Sponsor: University of Medicine and Dentistry of New Jersey
Terminated
principal Investigator left institution
Other terminated trials from University of Medicine and Dentistry of New Jersey
- Port-wine Mark · Phase PHASE1 · Feb 2019
- Low Back Pain · Phase NA · Jul 2015
- Acute Respiratory Distress Syndrome · Phase NA · Mar 2010
- Hyperglycemia · Phase NA · Jan 2009
- Neurotoxicity Syndromes · Phase NA · May 2007
See all terminations from University of Medicine and Dentistry of New Jersey
Listed as NCT00176618, this NA trial focuses on Aberrant Crypt Foci and remains terminated or withdrawn. Sponsored by University of Medicine and Dentistry of New Jersey, it has been updated 6 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2018 — Jan 2021 [monthly]
Terminated NA
-
Feb 2017 — Jun 2018 [monthly]
Terminated NA
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Terminated NA
First recorded
Apr 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Medicine and Dentistry of New Jersey
For direct contact, visit the study record on ClinicalTrials.gov .